KeyCorp Cuts ICU Medical (NASDAQ:ICUI) Price Target to $191.00

ICU Medical (NASDAQ:ICUI - Get Free Report) had its target price cut by analysts at KeyCorp from $209.00 to $191.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the medical instruments supplier's stock. KeyCorp's target price points to a potential upside of 40.79% from the stock's previous close.

A number of other equities research analysts also recently weighed in on the company. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Raymond James set a $97.00 target price on ICU Medical in a research report on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, April 16th. Two research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, ICU Medical has an average rating of "Moderate Buy" and a consensus target price of $162.67.

ICU Medical Price Performance

ICUI stock traded down $1.50 during midday trading on Monday, reaching $135.66. The company had a trading volume of 164,550 shares, compared to its average volume of 273,236. The firm has a 50-day moving average price of $143.81 and a 200-day moving average price of $158.23. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market capitalization of $3.33 billion, a P/E ratio of -29.68 and a beta of 0.86. ICU Medical has a 1 year low of $94.19 and a 1 year high of $196.26.

Institutional Investors Weigh In On ICU Medical

A number of large investors have recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical during the fourth quarter worth about $33,000. Quarry LP lifted its holdings in ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after buying an additional 214 shares during the period. Murphy & Mullick Capital Management Corp bought a new stake in ICU Medical in the fourth quarter valued at $52,000. Venturi Wealth Management LLC increased its position in ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares during the period. Finally, Russell Investments Group Ltd. boosted its stake in shares of ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.